The anticancer activity of NSAIDs is believed to be due to inhibition of cyclooxygenase (COX)-2, which is over-expressed in many types of cancer, including breast cancer, and plays a major role in tumorigenesis [8,9]. Here, PTGS2 is linked to breast cancer.